Figure 1. Chromosome Locations of Mouse Genes Associated with Autoimmune Disease
We have positioned 38 murine disease loci (horizontal bars) according to the marker locus most linked to the trait from genome scanning experiments. Where appropriate, Ϯ 5 cM confidence intervals are indicated with vertical bars. Loci colored red are linked to type 1 diabetes, those colored purple to SLE or SLE-associated autoantibody production (or both), those colored blue to EAE, those colored pink to EAO, and those colored green to AOD.
There are currently 13 separate type 1 diabetes non-MHC loci mapped (Idd2 through Idd15; Chesnut et al., 1993; de Gouyon et al., 1993; Ghosh et al., 1993; McAleer et al., 1995; Morahan et al., 1994; Serreze et al., 1994; Wicker et al., 1995) (Idd8 and Idd11 are probably the same locus). Nine separate loci (excluding lpr/Fas and gld/Fas ligand; Nagata and Suda, 1995) have been linked to SLE or to SLE-associated autoantibody production (or both) (Sle1-Sle3 [Morel et al., 1994] , Lbw2, Lbw3, and Lbw5-Lbw7 [Kono et al., 1994] , and nba1 [Drake et al., 1994] ; it is probable that Sle1 is equivalent to Lbw7 and Sle3 is equivalent to Lbw5), five in EAE (eae) (Baker et al., 1995; Sundvall et al., 1995) , three in EAO (Orch3, Orch4, and Orch5; Meeker et al., 1995) , and two in AOD (Aod1 and Aod2; Teuscher et al., 1996; Wardell et al., 1995) . Loci such as Lbw4 and Lbw8 (Kono et al., 1994) , which had statistical support of p > 0.003, were not included. The loci eae4 (chromosome 7), eae5 (chromosome 11), and eae6 (chromosome 18) are named here for convenience; although linkage data were reported by Baker et al. (1995) with support at p < 0.003, the possibility of segregation distortion was not eliminated. Map distances are based on the version 3.1 of the Mouse Genome Database, which contains additional information and references for all loci. Additional genes shown are as follows: Il1r1 and Il1r2 (interleukin-1 receptor 1 and 2), Ctla4, Cd28, Bcl2, Nramp1 (natural resistance-associated macrophage protein), and Lshs (unofficial nomenclature) on chromosome 11, which controls T cell responsiveness to interleukin-12 and susceptibility to Leishmania infection (Guler et al., 1996) . Periinsulitis, sialitis, hyperimmunoglobulin production, and resistance of T cells to apoptosis in NOD mice have been mapped to the Bcl2 locus, named here as Nod1 (Garchon et al., 1994) . Nod1 overlaps with the SLE-associated Sbw1 locus (splenomegaly) (Kono et al., 1994) , which affects lymphoid hyperplasia and hypereactivity. Sbw2 on chromosome 4 (Kono et al., 1994 ) is probably the same as Sle2 (Morel et al., 1994) . Interleukin-1 receptor antagonist (Il1rn) on chromosome 2 has been associated with, but not linked to, a number of human autoimmune diseases (Blakemore et al., 1995) . The Idd13 locus maps to the interleukin-1 gene on chromosome 2 (Serreze et al., 1994) . Il2 (interleukin-2) maps to the 4 cM congenic interval of Idd3 (Lord et al., 1995) , overlapping with Aod2 (Teuscher et al., 1996) . Aia1 is a locus controlling autoimmune hemolytic anemia on chromosome 4 that overlaps with the Idd9 and nba1 loci. The D6Nds1/Idd locus was detected in a NOD ϫ Mus spretus backcross and maps close to Igk (immunoglobulin light chain locus) (de Gouyon et al., 1993) and Tcrb (T cell receptor ␤-chain). The D6Mit52/Idd linkage was observed in a cross of NOD with NON (McAleer et al., 1995) and might be distinct from Idd6. Nod3 signifies a locus linked to dexamethazone resistance/apoptosis of NOD T cells and colocalizes with Idd6 (Penha-Goncalves et al., 1995) . Idd7 and Sle, a locus linked in the MRL-lpr mouse, colocalize at the centromere of chromosome 7 with the candidate gene Tgfb1 (Watson et al., 1992) . Nod2 is a subphenotype of NOD involving a T cell proliferative defect mapping to the marker D11Mit38, which is in a cluster of immunomodulatory genes, the ␤-chemokines (Gill et al., 1995) . Igh is the immunoglobulin heavy chain locus on chromosome 12. H2 is the MHC on chromosome 17. Mbp is the myelin basic protein gene on chromosome 18 and does not overlap with eae6 (Baker et al., 1995) . Note that the Sle1 10 cM interval overlaps with Fasl (Morel et al., 1994) . Bphs is the Bordetella pertussis-induced histamine sensitization locus, involved in both EAO and EAE susceptibility (Sudweeks et al., 1993) .
For the published human IDDM2-IDDM5, IDDM7, and IDDM8 loci on chromosomes 11p15 (Bennett et al., 1995) , 15q26 (Field et al., 1994 ), 11q13 (Davies et al., 1994 Hashimoto et al., 1994 ), 6q25 (Davies et al., 1994 , 2q31 (Copeman et al., 1995; Owerbach and Gabbay, 1995) , and 6q27 (Luo et al., 1995) ,respectively, the nearest genes that have been mapped in both mouse and humans were selected and placed in the figure according to the position of the mouse gene, e.g., the human thrombospondin gene is in the vicinity of IDDM8 on chromosome 6q27, Risch, 1987 to autoimmune response (Sudweeks et al., 1993) , such d Brown and Wordsworth, 1996 as the expression of an organ-specific antigen and its e Satsangi et al., 1996 specific interaction with the class II and class I molef Hochberg, 1987 cules of the MHC . Note that in Figure   g Guilleminault et al., 1989 1 several loci are shown that are linked to autoimmune h Gregory and Bassendine, 1994 disease-associated phenotypes such as apoptosis (Nod3 on chromosome 6) (Penha-Goncalves et al., 1995), T cell and B cell activity (Nod1, Sbw1 and Sbw2, from the expected Mendelian ratios (1:1 for a backcross and Nod2 on chromosomes 1, 4, and 11; Garchon et and 1:2:1 for an intercross) if a marker locus is near a al. , 1994; Gill et al., 1995; Kono et al., 1994) , and susceptidisease locus. Cross-progeny without disease are esbility to infectious diseases (Nramp1 [Vidal et al., 1995] sential controls, and it is also important to establish and Lshs [Guler et al., 1996] on chromosomes 1 and that the marker allele frequencies in all progeny (or a 11), which may influence autoimmunity via dysregulation randomly selected subset) do not vary from the Mendeof the immune system, e.g., by perturbing the Th1/Th2 lian ratios. Sample sizes are absolutely critical for the balance. reliability of genome scan results. Small sample sizes, say less than 50 mice, will have a high false-positive rate, where false-positive results are simply random Modes of Inheritance fluctuations. False-positive results can be reduced or Key information can be obtained about the relation bemade highly unlikely by replicating the results in more tween the action of disease gene products and the numthan one cross and by taking a low probability (p) value ber and effect of loci linked to the disease observed in as a statistical threshold for significance. In murine autothe genome scan by analysis of the frequency of disease immune disease models, p < 0.001 has been taken as in the parental strains and the F1, BC1, and F2 progeny. sufficient evidence to name a locus in a genome scan Only 13% of progeny of a (NOD ϫ C57BL/10.H2 g7 ) ϫ and undertake more experiments to confirm it. For ex-NOD backcross developed diabetes, which is much less ample, of 13 separate non-major histocompatibility than the 45% frequency expected if a single, fully recescomplex (MHC) Idd loci named, there is additional, indesive-acting gene was segregating and 7-fold less than pendent support for 12 of them (Idd15 has not yet been the 90% frequency observed in parental female NOD tested; Figure 1 ). Nevertheless, even more stringent mice. If such a locus existed, it would have a genotypic statistical criteria have been suggested (Lander and risk ratio (GRR) (the total number of affected progeny/ .
two times the number of homozygous affected progeny) of 0.5, i.e., all affected progeny would have the NOD Map Positions homozygous genotype at the disease locus (Risch et In themselves, map positions are important because al., 1993). Hence, there must be more than one gene they suggest candidate genes already mapped to the segregating. Genome scanning revealed that Idd2 disease gene interval. Figure 1 summarizes currently through Idd10 were segregating, but these genes still did not account for the 7-fold decrease in disease frequency from NOD parental mice to backcross progeny. The GRRs for these nine Idd loci were, respectively, 0.84, and 0.72. Note that none of the loci is fully recessive with a GRR of 0.5 and that the GRRs of Idd7 and Idd8 of the donor strain to the recipient (Frankel, 1995) . Thus, it is possible to compare two strains of mice differing exceed 1.0, indicative of genes in which the susceptibility is contributed from the resistant strain.
only for a specific chromosome segment. The construction of congenic strains has proved that chromosome Two main genetic models were fitted to the backcross data: the multiplicative model, which is a special model 3 has two separate but linked Idd loci (Wicker et al., 1994) , Idd3 and Idd10, that interact in synergistic way of epistasis with simple mathematical properties (relative penetrances are multiplied) and is approximately (Wicker et al., 1994) and has narrowed the Idd3-containing region down to 4 cM (Lord et al., 1995) . Congenic equivalent to the classic polygenic threshold liability model (in the liability model, the data from the measured strains for the MHC have proved invaluable in sorting out the relative contributions of MHC-linked genes and phenotypes are transformed into a logarithmic or logistic scale so that they can be added together); and, second, non-MHC-linked genes (Ikegami et al., 1995; . Once it is established that the specific region the heterogeneity model, in which genes act independently of each other and can substitute for each other contains a disease gene, the gene can be mapped to 0.1 cM by developing further congenic strains. (Risch et al., 1993) . Epistasis or gene interaction implies that the disease gene products interact, in contrast with heterogeneity, in which the defective proteins are causHuman Autoimmune Disease ing etiologically distinct forms of the disease. At the Clustering of disease in families is caused by environoutset, the heterogeneity model could be rejected bemental factors, genetic factors, or both. The degree of cause the frequency of disease in the backcross progclustering of disease in families can be estimated from eny was less than 45%. Statistically, the multiplicative the ratio of the risk for siblings of patients with a disease model fit the data better than the heterogeneity model. and the population prevalence of that disease (Risch, Nevertheless, when the GRRs for all nine of the detected 1987) (Table 1) . If this ratio, s , is close to 1.0, then there loci were multiplied together, the overall product was is no evidence for familial clustering. Note, however, for 0.36, which is greater than the experimental value of the 12 diseases listed in Table 1 , the s value greatly 0.14 (calculated by dividing the proportion of mice with exceeds 1.0, ranging from 6-100. For example, if a family diabetes in the backcross progeny [0.13] by the proporhas a child with type 1 diabetes, then the other siblings tion of parental NOD mice that develop diabetes [0.9]).
are at a 15 times greater risk of developing diabetes Therefore, there must be a large number of additional than a member of the general population. It cannot be genes with small, undetectable effects segregating in assumed that genes are fully responsible, because envithe cross (Risch et al., 1993) . Similar conclusions have ronmental factors can also cause familial clustering. been reached in plant genetics, in which relatively few However, it has recently been shown for multiple sclerogenes account for the bulk of variation in many populasis, by comparing the frequency of disease in biological tions, with ever-larger numbers of genes contributing and nonbiological relatives, that familial clustering has ever-smaller portions of the remaining variance (Patera genetic basis (Ebers et al., 1995) . The alternative stratson, 1995). egy is to embark on a genome scan, if large enough In the genetic analyses of murine autoimmunity renumbers of families with multiple affected cases are ported to date, there is no significant evidence for heteravailable. ogeneity, and instead epistasis is inferred. It appears
In type 1 diabetes, two genome scans (over 250 markthat the most likely mode of inheritance for autoimmune ers) have been completed on 61 (Hashimoto et al., 1994 ) traits in mice, including EAE (Baker et al., 1995; Sundvall and 96 (Davies et al., 1994) families with two or more et al., 1995), type 1 diabetes (McAleer et al., 1995) , and siblings both affected by disease. If available, other af-SLE (Morel et al., 1994) , is an epistatic one, with the fected relatives can be used, as can pedigrees with following characteristics: no single allele is sufficient or, larger numbers of affected individuals in more than one in general, necessary to cause the disease; the more generation, but affected sibling pairs are often the most susceptibility alleles at unlinked loci an individual has, common and the most easily collected. The main conthe greater the risk of developing the disease; the risks clusion was that the MHC-linked locus IDDM1 is probaattributable to the main loci are roughly equal; combinably the major locus and that a number of other genes tions of genes cause the disease, but more than one with lesser effects probably contribute to familial cluscombination may exist; and a significant component will tering. This conclusion is remarkably, but not unexpectprobably remain unmapped owing to the existence of edly, similar to that reached from genome scanning of many genes with weak effects.
the NOD mouse. Moreover, in line with the epidemiological results from multiple sclerosis, it appears likely that familial clustering could well be explained by the sharing Mouse Congenic Strains Not one of the mapped non-MHC susceptibility genes of susceptibility alleles at multiple loci (Todd, 1995) . For affected sibling pairs (or other relative pairs), the in Figure 1 has yet been identified. Owing to the reduced penetrance of susceptibility alleles, fine mapping by contribution of a single locus to familial clustering can be estimated from the linkage data (Risch, 1987) , which generating standard backcrosses or intercrosses is not productive unless an extreme penetrant trait is available.
in the case of type 1 diabetes was the distribution of marker alleles in the affected sibling pairs. In families Definitive fine mapping can be achieved by the construction of congenic strains in which specific chromosome from the United Kingdom, the s value for MHC is about 2.4, much less than the overall s value of 15, implying segments from the donor strain are introduced into the genome of the recipient strain by repetitive backcross that more genes may be involved. Similar conclusions were reached for multiple sclerosis and celiac disease marker and the disease mutation, there will still be a strong chance that the same marker alleles are associ- (Risch, 1987) , and it is evident from Table 1 that the MHC cannot fully account for familial clustering of rheumatoid ated with the susceptibility allele of the disease mutation in present-day chromosomes. This is called linkage disarthritis, ankylosing spondylitis, ulcerative colitis, and Crohn's disease. If the s of the disease is large (greater equilibrium; alleles at marker loci more than 1 cM away from the disease mutation will not tend to be associated than 6, for example) and the linkage of the MHC region in families cannot account for it, then a genome scan with alleles of the disease mutation, because recombination with other chromosomes bearing different alleles is warranted.
In human type 1 diabetes, we expect epistasis beat the microsatellite markers will have occurred frequently enough to scramble the association of alleles cause the risk to first, second, and third degree relatives decreases more rapidly than would be expected for a such that they reach equilibrium and become randomly associated. For example, if alleles at two linked markers heterogeneity model, in which risk would decrease in a linear fashion by 50% from first to second and 50%
each have a population frequency of 0.25, then the chance of them occurring on the same chromosome is from second to third degree relatives (Rich, 1990; Risch, 1990) . This is precisely analogous to the drastic reduc-0.25 ϫ 0.25 (0.06). However, if they are very close to each other on the chromosome, they will tend to occur tion in NOD diabetes frequency from that observed in the parental strain (90%) to that in the backcross progeny together on the same chromosome at a frequency greater than 0.06. (13%). Preliminary studies suggest that the MHC IDDM1 locus on chromosome 6p21 and the insulin gene minisaIn regions of the genome that show some evidence of linkage to disease detected in the genome scan, tellite locus IDDM2 on chromosome 11p15 interact epistatically (Cordell et al., 1995) .
therefore, testing markers every centimorgan should yield a marker that shows linkage disequilibrium with In genome scans, linkage results that have occurred through random fluctuation are expected, referred to as disease. By characterizing new markers in the 1 cM region flanking the first disease-associated marker, the false positives Risch, 1991) . They can be eliminated by testing additional, independisease mutation can be located to regions smaller than 1 cM, or approximately 10 6 bp of DNA, by finding markers dent data sets. The proportion of false-positive results among true positives can be reduced by using large with alleles that show stronger and stronger association with the disease. For the IDDM2 mutation this process, data sets, a map with denser markers, and multipoint programs Weeks and called linkage disequilibrium mapping, reduced the maximal chromosome region to only 4 ϫ 10 3 bp of DNA Lathrop, 1995), which make the map even more informative, and by correcting for the testing of multiple genetic (Lucassen et al., 1993) . This approach is very powerful and much more sensitive than linkage analysis in famiand clinical models (Risch, 1991) .
Taking all the current mouse and human data tolies. For example, the statistical support in all the combined available type 1 diabetic families for linkage of gether, environmental factors are probably not a major cause of familial clustering (Ebers et al., 1995; Todd, IDDM2 is marginal (p ϭ 0.005 in 568 affected sibling pair families; s ϭ 1.3), but the evidence for linkage 1995). This does not mean that environmental factors are not important. They must be important in type 1 disequilibrium at IDDM2 is overwhelming (p ϭ 6.7 ϫ 10 Ϫ14 ) (Bennett et al., 1996; Spielman et al., 1993) . Curdiabetes to explain seasonal and geographical variations in incidence, variations in disease frequency assorently, it is impractical and statistically problematical to scan the whole human genome for linkage disequilibciated with emigration, and the dramatic increase in disease incidence observed over the last 30 years. rium with 3000 markers, but in regions of linkage spanning 20 cM it is a feasible strategy. Already, there is Hence, environmental factors exist but are probably common and ubiquitous, affecting the general populaevidence for the association of a microsatellite allele with type 1 diabetes in a region of chromosome 2q that tion. We predict that individuals that carry susceptibility alleles at most disease loci will probably be at high risk showed weak evidence of linkage in the genome scan (Copeman et al., 1995) . The history of the populations of developing disease, in much the same way that the selected strains of NOD and (NZB ϫ NZW)F1 are studied and the age of the disease mutation relative to uniquely susceptible to disease because they carry susthe age of marker alleles are important factors (Jorde, ceptible alleles at many loci. 1995) . Linkage disequilibrium studies are best carried out in families, but these families do not have to have multiple affected children, but instead one affected child Fine Mapping in Humans Ironically, after genome scanning has been carried out, is sufficient (Copeman et al., 1995; Spielman et al., 1993; Thomson, 1995) . Families with one affected child are fine mapping and etiological mutation identification in humans may proceed faster than in mice because humuch more common than families with multiple cases and are therefore much easier to collect. mans are outbred. Consider a disease mutation that arose on a human chromosome 2000 years ago. It will Until recently the candidate gene approach dominated the genetic analysis of autoimmunity. Candidate be flanked by microsatellite markers with certain alleles, and hence if those microsatellites could be typed, their genes are, however, numerous, and aside from the MHC in several diseases and the insulin gene in type 1 diabealleles would give a specific and recognizable signature to the chromosome region containing the disease mutates, associations of many candidate genes have been reported but not confirmed. Nevertheless, candidate tion. If a marker is very close, within 1 cM (Jorde, 1995) , to a disease mutation, then despite 2000 years of opporgenes in regions of linkage, or better still in regions of linkage disequilibrium, do warrant some priority. tunities for recombination during meiosis between the
